APYX · Apyx Medical Corp
United States · RS rating 28 · As of 2026-11-03
| Price | 2.60 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 56 / 15 / 40 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 6 / 19 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +48.8% |
| Distance from 52-week high | +46.5% |
| Market cap (USD) | $159.0M |